Jean-Pierre Bizzari
Board Member
Aprea Therapeutics, Inc. (APRE)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Jean-Pierre Bizzari
Jean-Pierre Bizzari is recorded as Board Member at Aprea Therapeutics, Inc. (APRE). Aprea Therapeutics, Inc. reported in an 8-K filed August 24, 2023 that Jean-Pierre Bizzari was appointed Class III director, effective August 23, 2023.
“Following Mr. Schade's resignation, on August 23, 2023, the Board appointed Dr. Jean-Pierre Bizzari as a Class III director, effective immediately, to serve until the Company's 2025 annual meeting of stockholders or until his earlier resignation or removal.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-08-23–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Aprea Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Oren Gilad CEO
- Richard Peters, M.D., Ph.D. Chairman, Board Member
- John Hamill CFO
- Scott M. Coiante CFO
- Greg Korbel COO
- Bernd Seizinger Board Member
- Fouad Namouni, M.D. Board Member
- Gabriela Gruia Board Member
- Gabriela Gruia, M.D. Board Member
- Marc Duey Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.